The Europe Amniotic Products Market would witness market growth of 6.9% CAGR during the forecast period (2023-2030).
The amnion, the placenta's innermost layer that can be employed for wound healing due to its bacteriostatic and analgesic qualities, is fueling the market's expansion. Growing awareness in recent years has led to an increase in transplants, which has increased demand for all of these tissue-based products. Additionally, it has increased contributions, which has fuelled market expansion.
The amniotic membrane is utilized during eye surgery as a biological bandage to repair or replace injured eye tissue. It is the perfect material for use on the eye's surface because it is thin, light, elastic, and nearly transparent. Chemical burns, conjunctival or corneal ulcers, disorders that result in severe ulceration, and surgical procedures requiring the removal of eye tissue are all treated with the amniotic membrane. Amniotic membranes are also used more frequently in ophthalmic surgery and other surgical procedures in dermatology, plastic surgery, urogenital medicine, and otorhinolaryngology.
Additionally, the amniotic membrane and its mesenchymal and epithelial cells have numerous uses in regenerative medicine and promise for cancer treatment. The amniotic membrane is a significant source of bioactive compounds that aid in wound healing.
In the UK, combating obesity is one of the nation’s major long-term health issues. Nowadays, over two-thirds (63%) of people are overweight, and approximately half are obese. One-third of children leaving primary school are overweight or obese, and one-fifth of youngsters are obese. According to OECD data, the percentage of obese adults in Germany quadrupled between 1990 and 2015, from 12.0% to 23.6%, and was – for the first time – considerably over the OECD average of 19.5% in 2015, placing it among the top ten nations with the highest obesity rates. The high prevalence of obesity and its associated health issues are anticipated to increase the demand for amniotic products as the obesity rises risk of ulceration. As a result, the demand for amniotic products is predicted to grow in the region.
The Germany market dominated the Europe Amniotic Products Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $97.9 Million by 2030. The UK market is estimated to witness a CAGR of 6% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 7.7% during (2023 - 2030).
Based on Type, the market is segmented into Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes. Based on Application, the market is segmented into Wound Care, Ophthalmology, Orthopedics, and Others. Based on End User, the market is segmented into Hospital & Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Amniotic Products Market is Projected to reach USD 1.6 Billion by 2030, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC
By Type
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
